No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CNS Cohen & Steers
- 71.580
- +2.240+3.23%
Close Apr 23 16:00 ET
- 71.640
- +0.060+0.08%
Post 16:00 ET
3.55BMarket Cap27.85P/E (TTM)
72.040High69.780Low485.72KVolume69.880Open69.340Pre Close34.62MTurnover1.88%Turnover Ratio27.53P/E (Static)49.53MShares77.94952wk High9.30P/B1.85BFloat Cap49.11452wk Low2.30Dividend TTM25.88MShs Float92.803Historical High3.21%Div YieldTTM3.26%Amplitude3.449Historical Low71.284Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Cohen & Steers First Quarter 2024 Earnings: Misses Expectations
Cohen & Steers Ends Sales Pact, Capitalizes on Equity Sales
Express News | Cohen & Steers Inc - on April 22 Delivered Written Notice to BofA Securities That It Was Terminating the Sales Agreement, Effective April 22
Cohen & Steers Closes Sale of 1 Million Shares
Cohen & Steers (CNS) said late Monday it sold more than 1 million shares at an average price of $69.60 apiece through an "at-the-market" equity offering program for net proceeds of about $68.4 million
Reported Earlier, Cohen & Steers Raises $70M In Gross Proceeds From At-The-Market Equity Offering
Cohen & Steers, Inc. (NYSE:CNS) has offered and sold 1,007,057 shares of its common stock (the "Shares") through its "at-the-market" equity offering program (the "ATM Program"). The Shares were offere
Cohen & Steers Raises ~$70M via ATM Equity Offering
Comments
Investor concerns grow over Cohen & Steers' high P/E ratio in relation to dwindling earnings and low predicted growth rate. Speculations suggest the excessive P/E ratio is driven by investor confidence in a business turnaround which may not be sustainable given current earnings and growth rates.
Cohen & Steers, Inc.'s (NYSE:CNS) Business Is Yet to Catch Up With Its Share PriceAn insider selling shares at a price lower than market value could reflect their belief in a fair lower price. Absence of purchases in the past year despite high insider ownership might cause concern. Usually, however, a high level of insider ownership is seen positively as it implies management's alignment with shareholder interests.
ColumnsToday's Pre-Market Stock Movers: AAL, ZS, DICE, Crude and More
Gapping up
In reaction to earnings/guidance:
• $New Relic(NEWR.US$ +3.8% (guidance),$American Airlines(AAL.US$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC.(DICE.US$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma(ALBO.US$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
In reaction to earnings/guidance:
• $New Relic(NEWR.US$ +3.8% (guidance),$American Airlines(AAL.US$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC.(DICE.US$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma(ALBO.US$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
6
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg